Douglas G. McCartney
- Co-authors
- J. N. KanferJulian N. KanferIndrapal N. SinghGiuseppe SorrentinoJay W. PettegrewR. MassarelliL. FreyszHiroshi Hattori
- Topics
- Cholinesterase and Neurodegenerative Diseases (10 papers)Phosphodiesterase function and regulation (6 papers)Neurological Disorders and Treatments (5 papers)
- Journals
- Biochemical and Biophysical Research CommunicationsFEBS LettersAnnals of the New York Academy of Sciences
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Douglas G. McCartney
25 papers receiving 389 citations
Peers
Comparison fields: 5 of 62
- Molecular Biology 265
- Physiology 128
- Cellular and Molecular Neuroscience 84
- Pharmacology 57
- Cell Biology 57
Countries citing papers authored by Douglas G. McCartney
This map shows the geographic impact of Douglas G. McCartney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas G. McCartney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas G. McCartney more than expected).
Fields of papers citing papers by Douglas G. McCartney
This network shows the impact of papers produced by Douglas G. McCartney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas G. McCartney. The network helps show where Douglas G. McCartney may publish in the future.
Co-authorship network of co-authors of Douglas G. McCartney
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas G. McCartney. A scholar is included among the top collaborators of Douglas G. McCartney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas G. McCartney. Douglas G. McCartney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 12 | |
| 3 | 24 | |
| 4 | 15 | |
| 5 | 34 | |
| 6 | 34 | |
| 7 | 14 | |
| 8 | 17 | |
| 9 | 11 | |
| 10 | 7 | |
| 11 | 22 | |
| 12 | 3 | |
| 13 | 7 | |
| 14 | 46 | |
| 15 | 1 | |
| 16 | 9 | |
| 17 | 25 | |
| 18 | 20 | |
| 19 | 31 | |
| 20 | 9 |
About Douglas G. McCartney
Douglas G. McCartney is a scholar working on Biochemistry, Neurology and Pharmacology, having authored 25 papers that have together received 405 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (10 papers), Phosphodiesterase function and regulation (6 papers) and Neurological Disorders and Treatments (5 papers). The work is most often cited by research in Biochemistry (55 citations), Physiology (128 citations) and Clinical Biochemistry (32 citations). Douglas G. McCartney has collaborated with scholars based in Canada, United States and France. Frequent co-authors include J. N. Kanfer, Julian N. Kanfer, Indrapal N. Singh, Giuseppe Sorrentino, Jay W. Pettegrew, R. Massarelli, L. Freysz, Hiroshi Hattori, John Moossy and Mutsuhiro Kobayashi. Their work appears in journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.